Cannabis company CB2 Insights Inc CBIIF has acquired New Jersey Alternative Medicine, one of the state’s largest medical cannabis evaluation and education clinic groups.
NJAM, which operates six clinics in the state and serves over 15,000 patients, will transfer all patient care to CB2 Insights under a performance-based agreement. CB2 Insights will operate in New Jersey under its subsidiary Canna Care Docs, the largest multistate medical cannabis clinic operator in the U.S.
Need more cannabis news? Check out all of our coverage here.
New Jersey is the third new state CB2 Insights has entered since April, following the recently announced acquisitions of Relaxed Clarity and MedEval Clinics in Colorado and Arizona, respectively.
“New Jersey is exciting territory right now, as regulators are now solidly focused on advancing legislation throughout the state," CB2 Insights CEO Prad Sekar told Benzinga.
"We are ready to bring our proven clinical model to help in the advancement of care to the tens of thousands of patients seeking cannabinoid therapy.”
Related Stories:
KushCo Will Open A Distribution Facility In Metro Detroit
Scoop: ParcelPal Inks Deal With Ontario Craft Brewery Cowbell
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.